0 Comentários
0 Compartilhamentos
1713 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Advancing Precision Oncology: Exploring Biomarkers For PARP Inhibitor Therapy In Cancer TreatmentPrecision medicine aims to match the right treatment to the right patient based on the molecular characteristics of their cancer. PARP inhibitors are one type of targeted therapy that has shown promise in certain breast and ovarian cancers linked to defective DNA repair pathways. However, identifying predictive biomarkers remains an active area of research to optimize patient selection and...0 Comentários 0 Compartilhamentos 1649 Visualizações 0 Anterior
- Alfa Cytology Announces Cancer Diagnostic Biomarker Development Services to Enhance Precision in Oncology ResearchAlfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker development services to advance personalized...0 Comentários 0 Compartilhamentos 194 Visualizações 0 Anterior
- Asia Pacific Precision Oncology Market: Key Trends and Market Opportunities Forecast 2032North America The North America Precision Oncology Market is well-established, primarily driven by advancements in cancer genomics and government-backed initiatives for personalized medicine. In the United States, substantial investments in genomics and cancer research by organizations like the National Cancer Institute (NCI) have propelled market growth. Canada is also investing in...0 Comentários 0 Compartilhamentos 95 Visualizações 0 Anterior
- Asia Pacific Precision Oncology Market: Key Trends and Market Opportunities Forecast 2032North America The North America Precision Oncology Market is well-established, primarily driven by advancements in cancer genomics and government-backed initiatives for personalized medicine. In the United States, substantial investments in genomics and cancer research by organizations like the National Cancer Institute (NCI) have propelled market growth. Canada is also investing in...0 Comentários 0 Compartilhamentos 95 Visualizações 0 Anterior
- Linear Accelerators: Pioneering Precision in Modern Radiation OncologyA linear accelerator, also called a linac, is a device that uses high frequency radio waves to accelerate charged particles to high energies used for applications such as external beam radiotherapy. Over the past few decades, linear accelerators have revolutionized cancer treatment by providing an efficient and effective way to deliver radiation doses to tumors. What is a Linear...0 Comentários 0 Compartilhamentos 1395 Visualizações 0 Anterior
- Non-Oncology Precision Medicine Market Analysis, Size, Share, and Forecast 2031The Non-Oncology Precision Medicine Market in 2023 is US$ 76.64 billion, and is expected to reach US$ 164.52 billion by 2031 at a CAGR of 10.00%. FutureWise Research published a report that analyzes Non-Oncology Precision Medicine Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain...0 Comentários 0 Compartilhamentos 1461 Visualizações 0 Anterior
- Non-Oncology Precision Medicine Market Focuses on Growth Factors, Technological Innovation, Forecast to 2029The Global Non-Oncology Precision Medicine Market report by MarketQuest.biz investigates past and current economic prospects and trends to gain valuable insights into these financial variables from 2023 to 2029. The research forecasts revenue for the Non-Oncology Precision Medicine market from 2023 to 2029, with 2021 as the base year. The study also provides the compound annual growth rate...0 Comentários 0 Compartilhamentos 2128 Visualizações 0 Anterior
- Oncology Precision Medicine Market Analysis, Size, Share, and Forecast 2031The Oncology Precision Medicine Market in 2023 is US$ 105.96 billion, and is expected to reach US$ 225.82 billion by 2031 at a CAGR of 9.90%. FutureWise Research published a report that analyzes Oncology Precision Medicine Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure....0 Comentários 0 Compartilhamentos 1510 Visualizações 0 Anterior
- Oncology Precision Medicine Market Size And Forecast Report 2024-2032Oncology Precision Medicine Market, Size, Share, Outlook | Forecast (2023 - 2028) | Renub Research Oncology Precision Medicine Market, Size, Global Forecast 2022-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis. The report also includes an analysis of the competitors, geographic regions, and expansion into Global Oncology Precision Medicine...0 Comentários 0 Compartilhamentos 317 Visualizações 0 Anterior
- Global Companion Diagnostic Market Set to Expand to US$ 32340 million by 2030 at 20.3 CAGRPragma Market Research and Business Consulting has published a new study titled "Companion Diagnostic Market: Size, Trends, and Insights" covering the market's dimensions, trends, and insights. Market Overview “According to the latest research study, the demand of global Companion Diagnostic Market size & share was valued at approximately US$ 8820 million in 2023 and is expected to...0 Comentários 0 Compartilhamentos 821 Visualizações 0 Anterior
- Market Dynamics: Assessing the Growth Potential of Patient-Derived Xenograft ModelsAdvancing Cancer Research: Exploring the Patient-Derived Xenograft Model Market Introduction: In the realm of oncology research, innovation is paramount in the quest to develop effective treatments for various cancers. Among the tools driving progress is the Patient-Derived Xenograft (PDX) model, a cutting-edge approach that mimics human cancer within animal hosts. The PDX model market is...0 Comentários 0 Compartilhamentos 1248 Visualizações 0 Anterior
- Oncology Precision Medicine Market Size And Forecast Report 2024-2032Oncology Precision Medicine Market, Size, Share, Outlook | Forecast (2023 - 2028) | Renub Research Oncology Precision Medicine Market, Size, Global Forecast 2022-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis. The report also includes an analysis of the competitors, geographic regions, and expansion into Global Oncology Precision Medicine...0 Comentários 0 Compartilhamentos 331 Visualizações 0 Anterior
- Oncology Precision Medicine Market, Size, Global Forecast 2028Oncology Precision Medicine Market, Size, Global Forecast 2022-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis. The report also includes an analysis of the competitors, geographic regions, and expansion into Global Oncology Precision Medicine Market. Global Oncology Precision Medicine Market is anticipated grow at a CAGR of 10.50% between...0 Comentários 0 Compartilhamentos 2085 Visualizações 0 Anterior
- Patient Derived Xenograft Model: An Innovative Platform for Precision Cancer MedicineA Patient Derived Xenograft (PDX) model is an innovative technique of transplanting fresh tumor tissue directly from a patient’s biopsy or surgical specimen into immune-deficient mice. The engrafted tumor tissue preserves key characteristics of the original patient tumor including genotype, phenotype and tumor microenvironment. Establishing a Patient Derived Xenograft Model In...0 Comentários 0 Compartilhamentos 112 Visualizações 0 Anterior
Páginas Impulsionadas